Pharmacovigilance
Rus
En
Es
Company
About company
History
Our mission
Quality
Social responsibility
Portfolio
Products
Pharmacovigilance
Scientific publications
Scientific developments
Pipeline
Scientific developments
Manufacture
Production in Obolensk
Production in Pushkin
To partners
Distributors
Export development
Press room
Company's news
Press kit
Gallery
Contacts
Contact
Main
/
Company's news
Company's news
Press about us
Press kit
Gallery
Contacts
Company's news
17.01.2024
GEROPHARM insulins have received a certificate of compliance with Islamic norms
29.12.2023
GEROPHARM brings back Ozempic® with a new name: Semavic®
1.11.2023
New ultra-rapid-acting insulin from GEROPHARM has been registered
6.10.2023
GEROPHARM Relaunched Ozempic® in Russia, Under the Name of Semavic®
6.10.2023
New medicinal product from GEROPHARM for the treatment of chronic prostatitis and benign prostatic hyperplasia
4.09.2023
GEROPHARM will assist in training staff for diabetes schools in Uzbekistan
16.08.2023
GEROPHARM sent insulins to Kyrgyzstan as humanitarian aid
28.07.2023
GEROPHARM took part in Russia–Africa Forum
Load more
You are a health care professional?
Yes
No
Go up